Study of PF-07985631 in healthy adults
This trial tests how a new medicine, PF-07985631, is tolerated and processed by the body in healthy adults. It helps researchers understand the right dosage and safety before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 45 years old (or up to 55 if you are of Japanese or Chinese descent).
- If you are Japanese or Chinese, all four of your biological grandparents must have been born in Japan or China.
- You cannot have any significant medical conditions (like heart, liver, kidney, or blood disorders) or a history of serious allergies to biologic medications.
- You must not have an active infection, recent fever, or tuberculosis, and you cannot have received any vaccines in the past 6 weeks.
- You need to have normal kidney function (eGFR at least 75 mL/min/1.73 m²) and no abnormal findings on chest X-ray or ECG.
- Your blood and urine tests at screening must be within healthy limits—no low blood cell counts, abnormal liver enzymes, or positive drug test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a new drug (LY3867070) in healthy volunteers to see how it's processed by the body and how safe it is. It includes a special part for Japanese and Chinese participants and involves skin patches and possibly a small skin biopsy.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.